Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HOLSTEBRO ØJENKLINIK I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   7.0% 6.4% 6.1% 5.1% 5.2% 7.3% 10.1% 9.9%   Credit score (0-100)   36 38 38 42 42 32 24 25   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   7,002 6,505 8,094 10,231 11,641 11,064 0.0 0.0   EBITDA   3,770 3,368 4,322 6,359 7,401 6,506 0.0 0.0   EBIT   3,465 3,150 4,166 6,231 7,327 6,432 0.0 0.0   Pre-tax profit (PTP)   3,449.0 3,136.2 4,148.8 6,202.6 7,301.9 6,426.9 0.0 0.0   Net earnings   3,449.0 3,136.2 4,148.8 6,202.6 7,301.9 6,426.9 0.0 0.0   Pre-tax profit without non-rec. items   3,449 3,136 4,149 6,203 7,302 6,427 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   849 752 596 467 393 320 0.0 0.0   Shareholders equity total   1,625 1,391 2,390 4,182 4,859 1,718 1,718 1,718   Interest-bearing liabilities   0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,314 2,414 3,352 4,676 5,258 2,229 1,718 1,718   Net Debt   -767 -771 -1,796 -3,169 -3,593 -761 -1,718 -1,718     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   7,002 6,505 8,094 10,231 11,641 11,064 0.0 0.0   Gross profit growth   2.4% -7.1% 24.4% 26.4% 13.8% -5.0% -100.0% 0.0%   Employees   6 6 6 7 7 8 0 0   Employee growth %   0.0% 0.0% 0.0% 16.7% 0.0% 14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,314 2,414 3,352 4,676 5,258 2,229 1,718 1,718   Balance sheet change%   7.8% 4.3% 38.8% 39.5% 12.4% -57.6% -22.9% 0.0%   Added value   3,769.6 3,367.5 4,322.0 6,359.3 7,455.5 6,505.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -227 -314 -313 -257 -148 -148 -320 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   49.5% 48.4% 51.5% 60.9% 62.9% 58.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   155.3% 133.2% 144.5% 155.2% 147.5% 171.8% 0.0% 0.0%   ROI %   223.2% 208.9% 215.7% 187.1% 162.0% 195.6% 0.0% 0.0%   ROE %   222.5% 208.0% 219.5% 188.7% 161.5% 195.4% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   70.2% 57.6% 71.3% 89.4% 92.4% 77.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -20.3% -22.9% -41.6% -49.8% -48.5% -11.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1,011.3% 0.0% 0.0% 1,022.3% 909.4% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   2.1 1.6 3.1 8.5 12.2 3.7 0.0 0.0   Current Ratio   2.1 1.6 3.1 8.5 12.2 3.7 0.0 0.0   Cash and cash equivalent   766.6 770.7 1,795.9 3,174.4 3,592.7 761.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   775.6 639.2 1,875.6 3,715.4 4,465.9 1,398.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   628 561 720 908 1,065 813 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   628 561 720 908 1,057 813 0 0   EBIT / employee   577 525 694 890 1,047 804 0 0   Net earnings / employee   575 523 691 886 1,043 803 0 0